Articles with public access mandates - Sagnik Nag, M.Sc., AMRSBLearn more
Not available anywhere: 2
CRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges
L Chacko, A Chaudhary, B Singh, S Dewanjee, R Kandimalla
Drug Discovery Today 28 (8), 103652, 2023
Mandates: Council of Scientific and Industrial Research, India
Revolutionizing Leishmaniasis Treatment with Cutting Edge Drug Delivery Systems and Nanovaccines: An Updated Review
S Tambe, S Nag, SR Pandya, R Kumar, K Balakrishnan, R Kumar, ...
ACS Infectious Diseases, 2024
Mandates: Department of Science & Technology, India
Available somewhere: 5
Exosome-based smart drug delivery tool for cancer theranostics
R Kar, R Dhar, S Mukherjee, S Nag, S Gorai, N Mukerjee, D Mukherjee, ...
ACS biomaterials science & engineering 9 (2), 577-594, 2023
Mandates: Science Foundation Ireland, Irish Research Council
Exploring the complex relationship between diabetes and cardiovascular complications: understanding diabetic cardiomyopathy and promising therapies
N Ghosh, L Chacko, H Bhattacharya, J Vallamkondu, S Nag, A Dey, ...
Biomedicines 11 (4), 1126, 2023
Mandates: Council of Scientific and Industrial Research, India
Unlocking exosome-based theragnostic signatures: deciphering secrets of ovarian cancer metastasis
S Mukherjee, S Nag, N Mukerjee, S Maitra, R Muthusamy, NK Fuloria, ...
ACS omega 8 (40), 36614-36627, 2023
Mandates: US National Institutes of Health
Role of exosomes in epithelial–mesenchymal transition
B Bhattacharya, S Nag, S Mukherjee, M Kulkarni, P Chandane, D Mandal, ...
ACS Applied Bio Materials 7 (1), 44-58, 2023
Mandates: Science Foundation Ireland, Irish Research Council
Clinical impact of epithelial–mesenchymal transition for cancer therapy
N Mukerjee, S Nag, B Bhattacharya, A Alexiou, D Mirgh, D Mukherjee, ...
Clinical and Translational Discovery 4 (1), e260, 2024
Mandates: Science Foundation Ireland, Irish Research Council
Publication and funding information is determined automatically by a computer program